Repository logo
 
Publication

Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021

2021-07-22Journal article Open access
Simple item page
dc.contributor.authorKissling, Esther
dc.contributor.authorHooiveld, Mariette
dc.contributor.authorSandonis Martín, Virginia
dc.contributor.authorMartínez-Baz, Iván
dc.contributor.authorWilliam, Naoma
dc.contributor.authorVilcu, Ana-Maria
dc.contributor.authorMazagatos, Clara
dc.contributor.authorDomegan, Lisa
dc.contributor.authorde Lusignan, Simon
dc.contributor.authorMeijer, Adam
dc.contributor.authorMachado, Ausenda
dc.contributor.authorBrytting, Mia
dc.contributor.authorCasado, Itziar
dc.contributor.authorMurray, Josephine-L.K.
dc.contributor.authorBelhillil, Sylvie
dc.contributor.authorLarrauri, Amparo
dc.contributor.authorO’Donnell, Joan
dc.contributor.authorTsang, Ruby
dc.contributor.authorde Lange, Marit
dc.contributor.authorRodrigues, Ana Paula
dc.contributor.authorRiess, Maximilian
dc.contributor.authorCastilla, Jesús
dc.contributor.authorHamilton, Mark
dc.contributor.authorFalchi, Alessandra
dc.contributor.authorPozo, Francisco
dc.contributor.authorDunford, Linda
dc.contributor.authorCogdale, Jade
dc.contributor.authorJansen, Tessa
dc.contributor.authorGuiomar, Raquel
dc.contributor.authorEnkirch, Theresa
dc.contributor.authorBurgui, Cristina
dc.contributor.authorSigerson, Debbie
dc.contributor.authorBlanchon, Thierry
dc.contributor.authorMartínez Ochoa, Eva María
dc.contributor.authorConnell, Jeff
dc.contributor.authorEllis, Joanna
dc.contributor.authorvan Gageldonk-Lafeber, Rianne
dc.contributor.authorKislaya, Irina
dc.contributor.authorRose, Angela M.C.
dc.contributor.authorGomez, Verónica
dc.contributor.authorNunes, Baltazar
dc.contributor.authorRoquette, Rita
dc.contributor.authorSilva, Adriana
dc.contributor.authorMelo, Aryse
dc.contributor.authorCosta, Inês
dc.contributor.authorVerdasca, Nuno
dc.contributor.authorConde, Patrícia
dc.contributor.authorValenciano, Marta
dc.contributor.authorI-MOVE-COVID-19 primary care study team
dc.date.accessioned2022-03-10T16:48:45Z
dc.date.available2022-03-10T16:48:45Z
dc.date.issued2021-07-22
dc.descriptionI-MOVE-COVID-19 primary care study team (in addition to authors above): Nick Andrews, Jamie Lopez Bernal, Heather Whitaker, Caroline Guerrisi, Titouan Launay, Shirley Masse, Sylvie van der Werf, Vincent Enouf, John Cuddihy, Adele McKenna, Michael Joyce, Cillian de Gascun, Joanne Moran, Ana Miqueleiz, Ana Navascués, Camino Trobajo-Sanmartín, Carmen Ezpeleta, Paula López Moreno, Javier Gorricho, Eva Ardanaz, Fernando Baigorria, Aurelio Barricarte, Enrique de la Cruz, Nerea Egüés, Manuel García Cenoz, Marcela Guevara, Conchi Moreno-Iribas, Carmen Sayón, Verónica Gomez, Baltazar Nunes, Rita Roquete, Adriana Silva, Aryse Melo, Inês Costa, Nuno Verdasca, Patrícia Conde, Diogo FP Marques, Anna Molesworth, Leanne Quinn, Miranda Leyton, Selin Campbell, Janine Thoulass, Jim McMenamin, Ana Martínez Mateo, Luca Basile, Daniel Castrillejo, Carmen Quiñones Rubio, Concepción Delgado-Sanz, Jesús Oliva.pt_PT
dc.description.abstractThe I-MOVE-COVID-19 network collates epidemiological and clinical information on patients with coronavirus disease (COVID-19), including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virological characterisation in 11 European countries [1]. One component of I-MOVE-COVID-19 is the multicentre vaccine effectiveness (VE) study at primary care/outpatient level in nine European study sites in eight countries. We measured overall and product-specific COVID-19 VE against symptomatic SARS-CoV-2 infection among those aged 65 years and older. We also measured VE by time since vaccination.pt_PT
dc.description.sponsorshipThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003673.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationEuro Surveill. 2021;26(29):pii=2100670. https://doi.org/10.2807/1560-7917.ES.2021.26.29.2100670pt_PT
dc.identifier.doi10.2807/1560-7917.ES.2021.26.29.2100670pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/7985
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherEuropean Centre for Disease Prevention and Controlpt_PT
dc.relationMultidisciplinary European network for research, prevention and control of the COVID-19 Pandemic
dc.relation.publisherversionhttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.29.2100670pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.subjectCOVID-19pt_PT
dc.subjectSARS-CoV-2pt_PT
dc.subjectVaccine Effectivenesspt_PT
dc.subjectElderlypt_PT
dc.subjectEstados de Saúde e de Doençapt_PT
dc.subjectDeterminantes da Saúde e da Doençapt_PT
dc.subjectEfetividade da vacina contra COVID-19pt_PT
dc.subjectInfecções Respiratóriaspt_PT
dc.titleVaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleMultidisciplinary European network for research, prevention and control of the COVID-19 Pandemic
oaire.awardURIinfo:eu-repo/grantAgreement/EC/H2020/101003673/EU
oaire.citation.issue29pt_PT
oaire.citation.titleEurosurveillancept_PT
oaire.citation.volume26pt_PT
oaire.fundingStreamH2020
project.funder.identifierhttp://doi.org/10.13039/501100008530
project.funder.nameEuropean Commission
rcaap.embargofctAcesso de acordo com política editorial da revista.pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublication7403e02d-5360-418c-8e37-687c3a1349f8
relation.isProjectOfPublication.latestForDiscovery7403e02d-5360-418c-8e37-687c3a1349f8

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
eurosurv-26-29_4.pdf
Size:
146.5 KB
Format:
Adobe Portable Document Format
Download

Collections

DEP - Artigos em revistas internacionais
DDI - Artigos em revistas internacionais